7Yamauchi T,Kamon J,ItoY,et al.Cloning of adiponectin receptors that mediate antidiabetic metabolic effects.Nature,2003,423(6941):762-769.
8Hug C,Wang J,Ah mad NS,et al.T-cadherin is a receptor for hexameric and high-molecular-Weight forms of Acrp30/adiponectin.Proc Natl Acad Sci USA,2004,101(28)10308-10313.
9Hara T,Fujiw ara H,Shoji T,et al.Decreased plasma adiponectin levels in young obese males.J Atheroscler Thromb,2003,10:234.
10Sneha Latha C,Mukesh B,Simon M,et al.Plasma adiponectin is an independent predictor of type 2 diabetes in asianidians.Diabetes care,2003,26:3266.
6Steppan C M,Bailey S T,Bhat S,et al. The hormone resistin links obesity to diabetes. Nature,2001,400:307-312.
7Deurenberg P, Weststrate JA, Seidell JC, et al. Body mass index as a measure of body fatness:age and sex-specific prediction formulas. Br J Nutr,1991,65:105-114.
8McTernan P G, McTernan C L,Chetty R,et al. Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab, 2002,87 : 2407-2411.
9Savage DB, Sewt er CP, Klenk ES, et al. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferatoractivated recep-tor-γ action in humans. Diabetes, 2001,50 : 2199-2202.
10Lee JH,Chan JL,Yiannakouris N,et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: crosssectional and interventional studies in normal,insulin-resistant,and diabetic subjects. J Clin Endocrinol Metab, 2003,88: 4848-4856.
4Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery:systematic review and meta analysis[J]. Am J Meal,2009,122(3) :248- 262.
5Kuzuya T, Nakagawa S, Satoh J, et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus[J]. Diabetes Res Clin Pract,2002,55(1) :65-85.
6Nelson D R. The cytochrome p450 homepage [J ]. Hum Genomics,2009,4(1) :59- 65.
7Mente A, Razak F, Blankenberg S, et al. Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance[J]. Diabetes Care, 2010,33 (7) : 1629- 1634.
8AMER P. Insulin resistance in type 2 diabetes: role of theadipokines [J]. CurrMolMed, 2005, 5 (3): 333 -339.
9HAFFNER S M. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease [J]. Am J Cardiol, 2006, 97 (2A): 3A-11A.
